Chlordiazepoxide Hydrochloride/Clidinium Bromide
- Product NDC
- 63629-2021
- 11-digit product format
- 636292021
- Labeler code
- 63629
- Product ID
- 63629-2021_b0860b45-12b4-4541-8f57-6fadbff48337
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chlordiazepoxide Hydrochloride and Clidinium Bromide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA213530
- Marketing category
- ANDA
- Marketing start
- 2020-10-20
- Marketing end
- 0000-00-00
- Substance
- CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
- Active strength
- 5 mg/1; mg/1
- Pharmacologic classes
- Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-2021-1 | 63629202101 | 100 CAPSULE in 1 BOTTLE (63629-2021-1) | 100 capsule | 2020-10-20 | 0000-00-00 | No | No | Current |